NEWS: 公告在東京證券交易所JASDAQ標準市場新上市

表紙
市場調查報告書

生物標誌物:技術與全球市場

Biomarkers: Technologies and Global Markets

出版商 BCC Research 商品編碼 995693
出版日期 內容資訊 英文 216 Pages
訂單完成後即時交付
價格
生物標誌物:技術與全球市場 Biomarkers: Technologies and Global Markets
出版日期: 2021年03月10日內容資訊: 英文 216 Pages
簡介

全球生物標誌物市場預計將在2020年達到433億美元,在2025年達到921億美元。

此外,預計2020年至2025年的複合年增長率為16.3%。

本報告分析了世界上生物標誌物的技術和市場趨勢,概述了產品和技術,市場的基本結構,主要的市場促進和限制因素以及市場規模,增長率趨勢的前景(直到2025年),按地區,產品類型,技術類型,治療領域,最終用戶,相關專利申請/認證趨勢,技術發展和臨床試驗進展,主要公司的概況的詳細趨勢,我們將收集並傳遞信息,例如。

目錄

第1章簡介

第2章摘要要點

第3章市場和技術背景

  • 生物標誌物的定義
  • 生物標誌物的分類
  • 生物標誌物的例子
  • 替代生物標誌物/終點
  • 生物標誌物的類型
  • 分子生物標誌物
  • 成像生物標誌物
  • 生物標誌物的發現,驗證和確認
  • 生物標誌物的發現和開發
  • 生物標誌物驗證
  • 生物標誌物的驗證
  • 臨床實施
  • 生物標誌物相容性測試
  • 生物標記分析中使用的技術
  • 基因組學
  • 蛋白質組學
  • 代謝組學
  • 成像
  • 生物信息學
  • 生物標誌物的應用
  • 診斷/治療/疾病監測
  • 藥物發現與開發
  • 臨床試驗(臨床試驗)
  • 個性化醫學

第4章按產品類型分類的市場

  • 生物標誌物市場:按產品類型
  • 市場概況
  • 市場收入
  • 市場份額
  • 生物標誌物產品:區域市場
  • 市場份額
  • 分析儀
  • 消耗品
  • 服務
  • 軟件

第5章按技術類型劃分的市場

  • 生物標誌物市場:按技術類型劃分
  • 市場概況
  • 市場收入
  • 市場份額
  • 基因組學
  • 蛋白質組學
  • 代謝組學
  • 成像
  • 生物信息學

第6章按治療區域劃分的細分市場

  • 按治療領域劃分的市場
  • 市場概況
  • 市場收入
  • 市場份額
  • 癌症
  • 心血管疾病/代謝疾病
  • 傳染病
  • 神經退行性疾□□病
  • 自身免疫性疾病
  • 其他疾病

第7章最終用戶的市場分類

  • 生物標誌物市場:按最終用戶劃分
  • 市場概況
  • 市場收入
  • 市場份額
  • 教育機構
  • 製藥和生物技術公司
  • 臨床研究組織(CRO)
  • 醫院/診斷

第8章行業結構

  • 行業趨勢
  • 商業合作/合作
  • 許可協議
  • 併購(併購)
  • 生物標誌物技術的領先製造商/供應商
  • 基因組學
  • 蛋白質組學
  • 代謝組學
  • 成像
  • 生物信息學

第9章臨床試驗

  • 臨床試驗趨勢:按治療領域分
  • 臨床試驗趨勢:按研究現狀
  • 臨床試驗趨勢:按研究階段劃分
  • 臨床試驗趨勢:包括兒童
  • 臨床試驗趨勢:按國家分類
  • 臨床試驗趨勢:按贊助商(資助者)

第10章專利分析

  • 與生物標誌物有關的專利
  • 案例研究
  • 案例研究:分子病理學協會訴Myriad Genetics Inc.
  • 案例研究:Roche Molecular Systems Inc.訴Cepheid
  • 專利分析
  • 專利數量:按年份
  • 專利數量:按申請
  • 專利數量:按公司
  • 專利數量:按國家
  • 專利數量:按受讓人的類型

第11章市場機會分析

  • 生物標誌物市場的優勢
  • 疾病發病率增加
  • 藥物開發成本和失敗
  • 組學和成像技術的進步
  • 監管支持
  • 商業合作/合作
  • 生物標誌物市場的挑戰
  • 技術問題
  • 監管問題
  • 技術工人要求
  • 生物標誌物開發成本高
  • 報銷醫療費用的挑戰
  • 生物標誌物市場的機會
  • 新興市場
  • 個性化醫學
  • 創新
  • 資金和研究促進
  • 對生物標誌物市場的威脅
  • 衝突
  • 監管和贖回問題
  • 新的冠狀病毒感染(COVID-19)傳播

第12章公司簡介

  • 10X GENOMICS
  • ABBOTT LABORATORIES LTD.
  • ABCAM PLC
  • AGILENT TECHNOLOGIES INC.
  • BAYER AG
  • BECKMAN COULTER LIFE SCIENCES
  • BECTON DICKINSON & CO.
  • BIOLEGEND
  • BIO-RAD LABORATORIES INC.
  • BIO-TECHNE CORP.
  • BRUKER CORP.
  • CANON MEDICAL SYSTEMS CORP.
  • CEPHEID
  • CREATIVE PROTEOMICS
  • CUBRESA INC.
  • CYTIVA
  • DANAHER CORP.
  • FUJIFILM VISUAL SONICS INC.
  • GE HEALTHCARE
  • F HOFFMANN-LA ROCHE AG
  • ILLUMINA INC.
  • INTEGRATED DNA TECHNOLOGIES (IDT)
  • JEOL LTD.
  • KONINKLIJKE PHILIPS N.V.
  • LANTHEUS MEDICAL IMAGING INC.
  • LECO CORP.
  • LEICA BIOSYSTEMS
  • LUMINEX CORP.
  • METABOLON INC.
  • MILLIPORE SIGMA
  • MOLECULAR DEVICES
  • OXFORD NANOPORE TECHNOLOGIES LTD.
  • PACIFIC BIOSCIENCES INC.
  • PERKINELMER INC.
  • PROMEGA CORP.
  • QIAGEN N.V.
  • QUANTERIX CORP.
  • SCIEX
  • SIEMENS HEALTHINEER AG
  • SHIMADZU CORP.
  • THERMO FISHER SCIENTIFIC INC.
  • WATERS CORP.

第13章附錄:縮寫詞/縮寫

目錄
Product Code: BIO061F

Highlights:

The global market for biomarkers should grow from $43.3 billion in 2020 to $92.1 billion by 2025, at compound annual growth rate (CAGR) of 16.3% for the period of 2020-2025.

The proteomics technology for biomarkers should grow from $18.4 billion in 2020 to $38.3 billion by 2025, at a CAGR of 15.8% for the period of 2020-2025.

The genomics technology for biomarkers should grow from $14.5 billion in 2020 to $31.5 billion by 2025, at a CAGR of 16.8% for the period of 2020-2025.

Report Scope:

BCC Research's new report, Biomarkers: Technologies and Global Markets, provides a comprehensive analysis of the biomarkers market in a global context, including market forecasts and sales through 2025. The report analyzes the market, segmenting it into various product offerings (i.e., instruments, consumables [reagents, kits and panels], services and software). Segmentation also provides analysis by popular technology type (genomics, proteomics and metabolomics, imaging and bioinformatics).

This study surveys the biomarker market by therapeutic area (cancer, cardiovascular and metabolic diseases, infectious diseases, neurodegenerative diseases, autoimmune diseases and others. End users include academic institutes, pharma and biotechnology companies, clinical research organizations, hospitals and diagnostics. Geographic regions include North America, Europe and Emerging markets. Emerging markets include countries like India, China, Korea, Taiwan, Africa, Australia, New Zealand, Canada, Latin America, etc.

This report features new product developments and patents that are boosting global growth in this market.

This report provides comprehensive profiles of market players in the industry. The industry structure chapter focuses on changing market trends, market players and leading products. This chapter also covers mergers and acquisitions and other collaborations or partnerships that are expected to shape the industry.

Strengths, weaknesses, threats and opportunities are expected to play a role in the diagnostic biomarkers market. These are evaluated in detail.

The scope of the report excludes in vitro diagnostic products and regulatory aspects. Digital biomarkers are not covered in this report.

Report Includes:

  • 48 data tables and 25 additional tables
  • An updated review and current landscape of the global biomarkers market
  • Analyses of the global market trends, with data from 2018-2020, and projections of compound annual growth rates (CAGRs) through 2025
  • Estimation of market size and market potential for global biomarkers market, and corresponding market share analysis by product type, technology type, therapeutic area, end user and geographic region for each market segment
  • Latest information on market opportunities and drivers, industry structure, regulatory frameworks, clinical trials and technological updates which are affecting the overall market growth
  • Identification of the leading biotechnology companies poised to introduce products during the forecast period, their impact on the face of the competitive environment and research priorities
  • Encompassing details of major types of biomarkers and their use in clinical trial assessment, drug discovery and development, and therapeutics
  • Review of patents issued for biomarker technologies and deep dive of the patent data by year, technology type, application, company, assignee and applicant country
  • Profile description of the of major market players, including Abbott Laboratories Ltd., Bayer AG, Bio-Rad Laboratories Inc., Canon Medical Corp., and Luminex Corp.

Table of Contents

Chapter 1 Introduction

  • Study Goals and Objectives
  • Reasons for Doing This Study
  • Scope of Report
  • Information Sources
  • Methodology
  • Geographic Breakdown
  • Analyst's Credentials
  • BCC Custom Research
  • Related BCC Research Reports

Chapter 2 Summary and Highlights

  • Key Highlights

Chapter 3 Market and Technology Background

  • Definitions of Biomarkers
  • Classification of Biomarkers
  • Examples of Biomarkers
  • Surrogate Biomarkers/Endpoints
  • Types of Biomarkers
  • Molecular Biomarkers
  • Imaging Biomarkers
  • Biomarker Discovery, Verification and Validation
  • Biomarker Discovery and Development
  • Biomarker Verification
  • Biomarker Validation
  • Clinical Implementation
  • Biomarker Qualification
  • Technologies Used in Biomarker Analysis
  • Genomics
  • Proteomics
  • Metabolomics
  • Imaging
  • Bioinformatics
  • Applications of Biomarkers
  • Diagnostics, Therapeutics and Disease Monitoring
  • Drug Discovery and Development
  • Clinical Trials
  • Personalized Medicine

Chapter 4 Market Breakdown by Product Type

  • Market by Biomarker Product Type
  • Market Overview
  • Market Revenue
  • Market Share
  • Market for Biomarker Products by Region
  • Market Shares
  • Instruments
  • Consumables
  • Services
  • Software

Chapter 5 Market Breakdown by Technology Type

  • Biomarker Market by Technology Type
  • Market Overview
  • Market Revenue
  • Market Share
  • Genomics
  • Proteomics
  • Metabolomics
  • Imaging
  • Bioinformatics

Chapter 6 Market Breakdown by Therapeutic Area

  • Market by Therapeutic Area
  • Market Overview
  • Market Revenue
  • Market Share
  • Cancer
  • Cardiovascular and Metabolic Diseases
  • Infectious Diseases
  • Neurodegenerative Diseases
  • Autoimmune Diseases
  • Other Diseases

Chapter 7 Market Breakdown by End User

  • Market by Biomarker End User
  • Market Overview
  • Market Revenue
  • Market Share
  • Academic Institutes
  • Pharma and Biotechnology Companies
  • Clinical Research Organizations (CROs)
  • Hospitals and Diagnostics

Chapter 8 Industry Structure

  • Industry Trends
  • Collaborations and Partnerships
  • License Agreements
  • Mergers and Acquisitions
  • Leading Manufacturers/Suppliers of Biomarkers Technologies
  • Genomics
  • Proteomics
  • Metabolomics
  • Imaging
  • Bioinformatics

Chapter 9 Clinical Trials

  • Clinical Trials by Therapeutic Area
  • Clinical Trials by Study Status
  • Clinical Trials by Study Phase
  • Clinical Trials of Studies including Children
  • Clinical Trials by Country
  • Clinical Trials by Sponsor

Chapter 10 Patent Analysis

  • Patents on Biomarkers
  • Case Studies
  • Case Study: Association for Molecular Pathology v. Myriad Genetics Inc.
  • Case Study: Roche Molecular Systems Inc. v. Cepheid
  • Patent Analysis
  • Patents by Year
  • Patents by Type
  • Patents by Application
  • Patents by Company
  • Patents, by Country
  • Patents by Type of Assignee

Chapter 11 Analysis of Market Opportunities

  • Strengths of the Biomarker Market
  • Rising Incidence of Diseases
  • Drug Development Costs and Failures
  • Advances in Omics and Imaging Technologies
  • Support from Regulatory Agencies
  • Collaborations and Partnerships
  • Challenges in the Biomarker Market
  • Technological Challenges
  • Regulatory Challenges
  • Requirement of Skilled Labor
  • High Development Cost of Biomarkers
  • Reimbursement Challenges
  • Opportunities in the Biomarker Market
  • Emerging Markets
  • Personalized Medicine
  • Innovation in Technology
  • Funding and Research Initiatives
  • Threats to the Biomarker Market
  • Competition
  • Regulatory and Reimbursement Challenges
  • COVID-19 Pandemic

Chapter 12 Company Profiles

  • 10X GENOMICS
  • ABBOTT LABORATORIES LTD.
  • ABCAM PLC
  • AGILENT TECHNOLOGIES INC.
  • BAYER AG
  • BECKMAN COULTER LIFE SCIENCES
  • BECTON DICKINSON & CO.
  • BIOLEGEND
  • BIO-RAD LABORATORIES INC.
  • BIO-TECHNE CORP.
  • BRUKER CORP.
  • CANON MEDICAL SYSTEMS CORP.
  • CEPHEID
  • CREATIVE PROTEOMICS
  • CUBRESA INC.
  • CYTIVA
  • DANAHER CORP.
  • FUJIFILM VISUAL SONICS INC.
  • GE HEALTHCARE
  • F HOFFMANN-LA ROCHE AG
  • ILLUMINA INC.
  • INTEGRATED DNA TECHNOLOGIES (IDT)
  • JEOL LTD.
  • KONINKLIJKE PHILIPS N.V.
  • LANTHEUS MEDICAL IMAGING INC.
  • LECO CORP.
  • LEICA BIOSYSTEMS
  • LUMINEX CORP.
  • METABOLON INC.
  • MILLIPORE SIGMA
  • MOLECULAR DEVICES
  • OXFORD NANOPORE TECHNOLOGIES LTD.
  • PACIFIC BIOSCIENCES INC.
  • PERKINELMER INC.
  • PROMEGA CORP.
  • QIAGEN N.V.
  • QUANTERIX CORP.
  • SCIEX
  • SIEMENS HEALTHINEER AG
  • SHIMADZU CORP.
  • THERMO FISHER SCIENTIFIC INC.
  • WATERS CORP.

Chapter 13 Appendix: Abbreviations/Acronyms

List of Tables

  • Summary Table : Global Market for Biomarkers, by Technology, Through 2025
  • Table 1 : Different Categories of Biomarkers
  • Table 2 : Examples of Biomarkers
  • Table 3 : Different Types of ELISAs
  • Table 4 : Global Market for Biomarkers, by Product Type, Through 2025
  • Table 5 : Global Market Shares of Biomarkers, by Product Type, 2019
  • Table 6 : Global Market for Biomarkers, by Region, Through 2025
  • Table 7 : Global Market Shares of Biomarkers, by Region, 2019
  • Table 8 : Global Market for Biomarker Instruments, by Region, Through 2025
  • Table 9 : Global Market for Biomarker Consumables, by Region, Through 2025
  • Table 10 : Global Market for Biomarker Services, by Region, Through 2025
  • Table 11 : Global Market for Biomarker Software, by Region, Through 2025
  • Table 12 : Global Market for Biomarkers, by Technology Type, Through 2025
  • Table 13 : Global Market Shares of Biomarkers, by Technology Type, 2019
  • Table 14 : Global Market for Genomics Biomarkers, by Region, Through 2025
  • Table 15 : Global Market for Proteomics Biomarkers, by Region, Through 2025
  • Table 16 : Global Market for Metabolomics Biomarkers, by Region, Through 2025
  • Table 17 : Global Market for Imaging Biomarkers, by Region, Through 2025
  • Table 18 : Global Market for Bioinformatics in Biomarkers, by Region, Through 2025
  • Table 19 : Global Market for Biomarkers, by Therapeutic Area, Through 2025
  • Table 20 : Global Market Shares of Biomarkers, by Therapeutic Area, 2019
  • Table 21 : Global Market for Cancer Biomarkers, by Region, Through 2025
  • Table 22 : Global Market for Cardiovascular and Metabolic Disease Biomarkers, by Region, Through 2025
  • Table 23 : Global and U.S. Prevalence, Common Infectious Diseases
  • Table 24 : Global Market for Infectious Disease Biomarkers, by Region, Through 2025
  • Table 25 : Global Market for Neurodegenerative Disease Biomarkers, by Region, Through 2025
  • Table 26 : Global Market for Autoimmune Disease Biomarkers, by Region, Through 2025
  • Table 27 : Biomarkers for Other Diseases
  • Table 28 : Global Market for Biomarkers for Other Diseases, by Region, Through 2025
  • Table 29 : Global Market for Biomarkers, by End User, Through 2025
  • Table 30 : Global Market Shares of Biomarkers, by End User, 2019
  • Table 31 : Global Market for Biomarkers in Academic Institutes, by Region, Through 2025
  • Table 32 : Global Market for Biomarkers in Pharma and Biotechnology, by Region, Through 2025
  • Table 33 : Global Market for Biomarkers in CROs, by Region, Through 2025
  • Table 34 : Global Market for Biomarkers in Hospitals and Diagnostics, by Region, Through 2025
  • Table 35 : Alliances in Global Biomarker Market, by Year, 2018-2020
  • Table 36 : Biomarker-Focused Consortia, 2002-2017
  • Table 37 : Collaborations/Partnerships in the Global Biomarker Market, 2018-January 2021
  • Table 38 : Licensing Agreements in the Global Biomarker Market, 2018-January 2021
  • Table 39 : Mergers and Acquisitions in the Global Biomarker Market, 2018-January 2021
  • Table 40 : Leading Manufacturers/Suppliers of Genomic Technologies, 2019
  • Table 41 : Global Market Shares of Leading Manufacturers/Suppliers of Genomic Technologies, 2019
  • Table 42 : Leading Manufacturers/Suppliers of Proteomic Technologies, 2019
  • Table 43 : Global Market Shares of Leading Manufacturers/Suppliers of Proteomics Technologies, 2019
  • Table 44 : Leading Manufacturers/Suppliers, Metabolomic Technologies, 2019
  • Table 45 : Global Market Shares of Leading Manufacturers/Suppliers of Metabolomic Technologies, 2019
  • Table 46 : Leading Manufacturers/Suppliers, Imaging Technologies, 2019
  • Table 47 : Global Market Shares of Leading Manufacturers/Suppliers of Imaging Technologies, 2019
  • Table 48 : Leading Manufacturers/Suppliers of Bioinformatics Technologies, 2019
  • Table 49 : Global Market Shares of Leading Manufacturers/Suppliers of Bioinformatics Technologies, 2019
  • Table 50 : Clinical Trials in Biomarkers, by Therapeutic Area, 2018-2020
  • Table 51 : Clinical Trials in Biomarkers, by Study Status, 2018-2020
  • Table 52 : Clinical Trials in Biomarkers, by Phase of the Study, 2018-2020
  • Table 53 : Clinical Trials in Biomarkers, Studies including Children, 2018-2020
  • Table 54 : Clinical Trials in Biomarkers, by Country, 2018-2020
  • Table 55 : Clinical Trials in Biomarkers, by Sponsor, 2018-2020
  • Table 56 : Representative Patents in Biomarkers, 2018-December 15, 2020
  • Table 57 : Patents Issued for Biomarkers, by Year, 2018-December 15, 2020
  • Table 58 : Patents Issued for Biomarkers, by Type, 2018-December 15, 2020
  • Table 59 : Patents Issued for Biomarkers, by Application, 2018-December 15, 2020
  • Table 60 : Patents Issued for Biomarkers, by Company, 2018-December 15, 2020
  • Table 61 : Patents Issued for Biomarkers, by Country, 2018-December 15, 2020
  • Table 62 : Patents Issued for Biomarkers, by Type of Assignee, 2018-December 15, 2020
  • Table 63 : Biomarkers with Letters of Support from the EMA, 2018-2020
  • Table 64 : Companion Diagnostics and Approved Drugs, 2017-2020
  • Table 65 : FoundationOne CDx Approved Indications
  • Table 66 : Abbott Laboratories: Biomarker Clinical Trials
  • Table 67 : Bayer: Biomarker Clinical Trials
  • Table 68 : Bio-Rad Laboratories: Biomarker Clinical Trials
  • Table 69 : GE Healthcare: Biomarker Clinical Trials
  • Table 70 : F Hoffmann-La Roche: Biomarker Clinical Trials
  • Table 71 : Millipore-Sigma: Biomarker Clinical Trials
  • Table 72 : Abbreviations in Biomarker Technologies and Global Markets Report

List of Figures

  • Summary Figure : Global Market for Biomarkers, by Technology, 2018-2025
  • Figure 1 : Different Categories of Biomarkers
  • Figure 2 : Molecular and Imaging Biomarkers
  • Figure 3 : Biomarker Discovery, Verification and Validation
  • Figure 4 : Biomarker Qualification Process
  • Figure 5 : Global Market for Biomarkers, by Product Type, 2018-2025
  • Figure 6 : Global Market Shares of Biomarkers, by Product Type, 2019
  • Figure 7 : Global Market for Biomarkers, by Region, 2018-2025
  • Figure 8 : Global Market Shares of Biomarkers, by Region, 2019
  • Figure 9 : Global Market for Biomarker Instruments, by Region, 2018-2025
  • Figure 10 : Global Market for Biomarker Consumables, by Region, 2018-2025
  • Figure 11 : Global Market for Biomarker Services, by Region, 2018-2025
  • Figure 12 : Global Market for Biomarker Software, by Region, 2018-2025
  • Figure 13 : Global Market for Biomarkers, by Technology Type, 2018-2025
  • Figure 14 : Global Market Shares of Biomarkers, by Technology Type, 2019
  • Figure 15 : Global Market for Genomics Biomarkers, by Region, 2018-2025
  • Figure 16 : Global Market for Proteomics Biomarkers, by Region, 2018-2025
  • Figure 17 : Global Market for Metabolomics Biomarkers, by Region, 2018-2025
  • Figure 18 : Global Market for Imaging Biomarkers, by Region, 2018-2025
  • Figure 19 : Global Market for Bioinformatics in Biomarkers, by Region, 2018-2025
  • Figure 20 : Global Market for Biomarkers, by Therapeutic Area, 2018-2025
  • Figure 21 : Global Market Shares of Biomarkers, by Therapeutic Area, 2019
  • Figure 22 : Global Market for Cancer Biomarkers, by Region, 2018-2025
  • Figure 23 : Global Market for Cardiovascular and Metabolic Disease Biomarkers, by Region, 2018-2025
  • Figure 24 : Global Market for Infectious Disease Biomarkers, by Region, 2018-2025
  • Figure 25 : Global Market for Neurodegenerative Disease Biomarkers, by Region, 2018-2025
  • Figure 26 : Global Market for Autoimmune Disease Biomarkers, by Region, 2018-2025
  • Figure 27 : Global Market for Biomarkers for Other Diseases, by Region, 2018-2025
  • Figure 28 : Global Market for Biomarkers, by End User, 2018-2025
  • Figure 29 : Global Market Shares of Biomarkers, by End User, 2019
  • Figure 30 : Global Market for Biomarkers in Academic Institutes, by Region, 2018-2025
  • Figure 31 : Global Market for Biomarkers in Pharma and Biotechnology, by Region, 2018-2025
  • Figure 32 : Global Market for Biomarkers in CROs, by Region, 2018-2025
  • Figure 33 : Global Market for Biomarkers in Hospitals and Diagnostics, by Region, 2018-2025
  • Figure 34 : Global Market Shares of Leading Manufacturers/Suppliers of Genomic Technologies, 2019
  • Figure 35 : Global Market Shares of Leading Manufacturers/Suppliers of Proteomics Technologies, 2019
  • Figure 36 : Global Market Shares of Leading Manufacturers/Suppliers of Metabolomic Technologies, 2019
  • Figure 37 : Global Market Shares of Leading Manufacturers/Suppliers of Imaging Technologies, 2019
  • Figure 38 : Global Market Shares of Leading Manufacturers/Suppliers of Bioinformatic Technologies, 2019
  • Figure 39 : Clinical Trials in Biomarkers, by Therapeutic Area, 2018-2020
  • Figure 40 : Clinical Trials in Biomarkers, by Study Status, 2018-2020
  • Figure 41 : Clinical Trials in Biomarkers, by Phase of the Study, 2018-2020
  • Figure 42 : Clinical Trials in Biomarkers, Studies including Children, 2018-2020
  • Figure 43 : Patents Issued for Biomarkers, by Year, 2018-December 15, 2020
  • Figure 44 : Patents Issued for Biomarkers, by Type, 2018-December 15, 2020
  • Figure 45 : Patents Issued for Biomarkers, by Application, 2018-December 15, 2020
  • Figure 46 : Patents Issued for Biomarkers, by Country, 2018-December 15, 2020
  • Figure 47 : Patents Issued for Biomarkers, by Type of Assignee, 2018-December 15, 2020
  • Figure 48 : Global Market for Biomarker SWOT Analysis